Truist Financial Corp Sells 4,504 Shares of Stryker Corporation $SYK

Truist Financial Corp cut its holdings in Stryker Corporation (NYSE:SYK) by 4.1% during the 4th quarter, Holdings Channel reports. The firm owned 104,123 shares of the medical technology company’s stock after selling 4,504 shares during the period. Truist Financial Corp’s holdings in Stryker were worth $36,596,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of SYK. Brighton Jones LLC grew its stake in shares of Stryker by 15.4% in the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after purchasing an additional 609 shares during the last quarter. Schnieders Capital Management LLC. bought a new stake in shares of Stryker in the second quarter worth about $205,000. Marshall Wace LLP grew its stake in shares of Stryker by 107.9% in the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock worth $2,255,000 after purchasing an additional 77,831 shares during the last quarter. Nebula Research & Development LLC bought a new stake in shares of Stryker in the second quarter worth about $219,000. Finally, HUB Investment Partners LLC bought a new stake in shares of Stryker in the second quarter worth about $253,000. 77.09% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

SYK has been the topic of several recent analyst reports. Barclays cut their target price on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday. BTIG Research cut their price objective on Stryker from $397.00 to $379.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a research report on Saturday. JPMorgan Chase & Co. cut their price objective on Stryker from $445.00 to $400.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Finally, TD Cowen cut Stryker from a “buy” rating to a “hold” rating and set a $387.00 price objective on the stock. in a research report on Monday, January 26th. Sixteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Stryker Stock Performance

Stryker stock opened at $295.39 on Wednesday. The stock’s 50 day simple moving average is $343.97 and its two-hundred day simple moving average is $356.28. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The stock has a market cap of $113.13 billion, a price-to-earnings ratio of 34.19, a PEG ratio of 1.72 and a beta of 0.80. Stryker Corporation has a fifty-two week low of $290.17 and a fifty-two week high of $404.87.

Stryker (NYSE:SYK) last released its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. During the same quarter in the previous year, the business posted $2.84 earnings per share. Stryker’s revenue for the quarter was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, analysts expect that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.